Who Holds Aytu Biopharma, Inc (AYTU)? 38 Institutional Holders, Q2 2026
Managers with more than $100 million in US equities report their holdings on Form 13F within 45 days of each quarter end. Quarter ended 30 Jun 2026: 38 holders, $8 million in total.
Largest holders
The 38 largest by value. Change in shares against Q1 2026.
| Manager | Shares | Value | Change | |
|---|---|---|---|---|
| Nantahala Capital Management, LLC | 1,086,812 | $2 million | +0% | 13F |
| Stonepine Capital Management, LLC | 912,921 | $2 million | +15% | 13F |
| AWM Investment Company, Inc. | 619,574 | $1 million | +0% | 13F |
| VANGUARD CAPITAL MANAGEMENT LLC | 261,146 | $561,464 | +0% | 13F |
| CROWN ADVISORS MANAGEMENT, INC. | 200,000 | $430,000 | +38% | 13F |
| DIADEMA PARTNERS LP | 148,546 | $319,374 | -58% | 13F |
| TWO SIGMA INVESTMENTS, LP | 105,326 | $226,451 | -14% | 13F |
| RENAISSANCE TECHNOLOGIES LLC | 104,823 | $225,369 | +12% | 13F |
| GEODE CAPITAL MANAGEMENT, LLC | 93,647 | $201,371 | +1% | 13F |
| CITADEL ADVISORS LLC | 49,414 | $106,240 | +34% | 13F |
| VANGUARD FIDUCIARY TRUST CO | 47,048 | $101,153 | +0% | 13F |
| DIMENSIONAL FUND ADVISORS LP | 45,326 | $97,451 | +4% | 13F |
| Persistent Asset Partners Ltd | 37,984 | $81,666 | -59% | 13F |
| NORTHERN TRUST CORP | 27,925 | $60,039 | +46% | 13F |
| BELLEVUE ASSET MANAGEMENT, LLC | 25,013 | $53,777 | +0% | 13F |
| BlackRock, Inc. | 22,793 | $49,005 | +0% | 13F |
| XTX Topco Ltd | 21,416 | $46,044 | -1% | 13F |
| Daytona Street Capital LLC | 10,000 | $22,350 | +0% | 13F |
| UBS Group AG | 2,377 | $5,110 | +43% | 13F |
| Tower Research Capital LLC (TRC) | 2,232 | $4,799 | +43% | 13F |
| ROYAL BANK OF CANADA | 378 | $1,000 | +950% | 13F |
| OSAIC HOLDINGS, INC. | 462 | $991 | +0% | 13F |
| JPMORGAN CHASE & CO | 154 | $337 | +0% | 13F |
| WELLS FARGO & COMPANY/MN | 127 | $273 | +0% | 13F |
| MORGAN STANLEY | 125 | $269 | +0% | 13F |
| BARCLAYS PLC | 50 | $108 | New | 13F |
| GROUP ONE TRADING LLC | 37 | $80 | +0% | 13F |
| BNP PARIBAS FINANCIAL MARKETS | 23 | $49 | +0% | 13F |
| SBI Securities Co., Ltd. | 10 | $22 | -9% | 13F |
| ACADIAN ASSET MANAGEMENT LLC | 10,237 | $22 | +0% | 13F |
| Rockefeller Capital Management L.P. | 10 | $22 | +0% | 13F |
| Farther Finance Advisors, LLC | 4 | $9 | New | 13F |
| VISION FINANCIAL MARKETS LLC | 2 | $5 | +0% | 13F |
| Arax Advisory Partners | 2 | $4 | New | 13F |
| Caitong International Asset Management Co., Ltd | 2 | $4 | +0% | 13F |
| JONES FINANCIAL COMPANIES LLLP | 1 | $2 | +0% | 13F |
| FNY Investment Advisers, LLC | 110 | $0 | +22% | 13F |
| TSFG, LLC | 1 | $0 | +0% | 13F |
Questions and answers
- How many institutions hold Aytu Biopharma, Inc?
- 38 managers reported Aytu Biopharma, Inc on Form 13F for the quarter ended 30 June 2026, against 37 the quarter before.
- Who is the largest institutional holder of Aytu Biopharma, Inc?
- Nantahala Capital Management, LLC, with 1,086,812 shares worth $2 million on its 13F for Q2 2026.
- How many institutions bought or sold out of Aytu Biopharma, Inc in Q2 2026?
- 3 managers reported a new position and 2 reported none after holding it the quarter before.
Source: SEC EDGAR, Form 13F (public domain). Counts and values as filed. Cite this page: Tamarly Intelligence, "Who holds Aytu Biopharma, Inc, Q2 2026", https://app.tamarly.ai/holders/aytu-biopharma, built from SEC EDGAR.
Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.